Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price shot up 16.3% on Thursday . The stock traded as high as $5.45 and last traded at $2.50. 470 shares traded hands during trading, a decline of 68% from the average session volume of 1,459 shares. The stock had previously closed at $2.15.
Silence Therapeutics Price Performance
The stock’s 50 day moving average is $5.62 and its two-hundred day moving average is $6.44.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Recommended Stories
- Five stocks we like better than Silence Therapeutics
- Insider Trades May Not Tell You What You Think
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Choose Top Rated Stocks
- 3 Penny Stocks Ready to Break Out in 2025
- Want to Profit on the Downtrend? Downtrends, Explained.
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
